BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1925735)

  • 1. Treatment of tularemia with imipenem/cilastatin sodium.
    Lee HC; Horowitz E; Linder W
    South Med J; 1991 Oct; 84(10):1277-8. PubMed ID: 1925735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastin dosage during acute renal failure and hemofiltration.
    Dehne MG; Kroh UF
    Intensive Care Med; 1995 Oct; 21(10):863. PubMed ID: 8557879
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
    Tegeder I; Bremer F; Oelkers R; Schobel H; Schüttler J; Brune K; Geisslinger G
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2640-5. PubMed ID: 9420033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 5. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
    Giacometti A; Pongetti P; Petrelli E; Scalise G
    J Chemother; 1990 Aug; 2(4):247-51. PubMed ID: 2230909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus.
    Asensi F; Otero MC; Pérez-Tamarit D; Rodríguez-Escribano I; Cabedo JL; Gresa S; Cantón E
    J Chemother; 1993 Apr; 5(2):133-4. PubMed ID: 8515296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin drug utilization evaluation in a large community hospital.
    Sesin GP
    DICP; 1991 Dec; 25(12):1399. PubMed ID: 1815448
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
    Asensi F; Pérez-Tamarit D; Otero MC; Gallego M; Llanes S; Abadia C; Cantó E
    Pediatr Infect Dis J; 1989 Dec; 8(12):895. PubMed ID: 2626294
    [No Abstract]   [Full Text] [Related]  

  • 10. Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
    O'Riordan J; Javed M; Doherty C; Hutchinson M
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):383. PubMed ID: 8158196
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs recently released in Belgium. Torasemide, nalbuphine, imipenem-cilastatin.
    Harvengt C
    Acta Clin Belg; 1987; 42(4):298-302. PubMed ID: 3270973
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.
    Mueller BA; Scarim SK; Macias WL
    Am J Kidney Dis; 1993 Feb; 21(2):172-9. PubMed ID: 8430678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin-induced acute eosinophilic pneumonia.
    Foong KS; Lee A; Pekez M; Bin W
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
    Au E; Tow A; Allen DM; Ang PT
    Ann Acad Med Singap; 1994 Nov; 23(6):819-22. PubMed ID: 7741492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE; Nord CE
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of imipenem-cilastatin in neonatal meningitis caused by Citrobacter diversus.
    Haimi-Cohen Y; Amir J; Weinstock A; Varsano I
    Acta Paediatr; 1993; 82(6-7):530-2. PubMed ID: 8338984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.